Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure.
Georg SemmlerSonia Alonso LópezMónica PonsSabela LensElton DajtiMarie GriemsmannAlberto ZanettoLukas BurghartStefanie Hametner-SchreilLukas HartlMarisa ManzanoSergio Rodriguez-TajesPaola ZanagaMichael SchwarzMaría L GutierrezMathias JachsAnna PocurullBenjamín PoloDominik EckerBeatriz MateosSonia IzquierdoYolanda RealLorenz BalcarJuan Antonio Carbonell-AsinsMichael GschwantlerFrancesco Paolo RussoFrancesco AzzaroliBenjamin MaasoumyThomas ReibergerXavier FornsJoan GenescàRafael BañaresMattias MandorferPublished in: Hepatology (Baltimore, Md.) (2024)
In patients with compensated advanced chronic liver disease, the risks of hepatic decompensation and HCC remain constant after HCV-cure, even in the long term (>3 y). One-time post-treatment risk stratification based on noninvasive criteria provides important prognostic information that is maintained during long-term follow-up, as the hazards remain proportional over time.